Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IncobotulinumtoxinA in Provoked Vestibulodynia
NCT07486830Phase 2Recruiting
- Sponsor
- The Centers for Vulvovaginal Disorders
- Start
- Feb 2026
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in vestibulodynia, sponsored by The Centers for Vulvovaginal Disorders. Started Feb 2026; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
vestibulodynia
Beyond the preview
Go deeper on NCT07486830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07486830.